BIO Commends Senate Committee On Small Business And Entrepreneurship’s SBIR Reauthorization
Submitted by Robert Lawrence on Friday, 19 June 2009No Comment
Under legislation reported by the Senate Committee on Small Business and Entrepreneurship, small companies that receive the majority of their financing from venture capital will once again be considered eligible to compete for Small Business Innovation Research (SBIR) grants. The change will allow more small biotechnology start-ups to compete for these funds and continue critical research and development of medical advancements and breakthroughs.
Leave a comment!